Kishiwada, M.; Mizuno, S.; Hayasaki, A.; Kaluba, B.; Fujii, T.; Noguchi, D.; Ito, T.; Iizawa, Y.; Tanemura, A.; Murata, Y.;
et al. Impact of Surgical Resection After Induction Gemcitabine Plus S-1-Based Chemoradiotherapy in Patients with Locally Advanced Pancreatic Ductal Adenocarcinoma: A Focus on UR-LA Cases. Cancers 2025, 17, 1048.
https://doi.org/10.3390/cancers17061048
AMA Style
Kishiwada M, Mizuno S, Hayasaki A, Kaluba B, Fujii T, Noguchi D, Ito T, Iizawa Y, Tanemura A, Murata Y,
et al. Impact of Surgical Resection After Induction Gemcitabine Plus S-1-Based Chemoradiotherapy in Patients with Locally Advanced Pancreatic Ductal Adenocarcinoma: A Focus on UR-LA Cases. Cancers. 2025; 17(6):1048.
https://doi.org/10.3390/cancers17061048
Chicago/Turabian Style
Kishiwada, Masashi, Shugo Mizuno, Aoi Hayasaki, Benson Kaluba, Takehiro Fujii, Daisuke Noguchi, Takahiro Ito, Yusuke Iizawa, Akihiro Tanemura, Yasuhiro Murata,
and et al. 2025. "Impact of Surgical Resection After Induction Gemcitabine Plus S-1-Based Chemoradiotherapy in Patients with Locally Advanced Pancreatic Ductal Adenocarcinoma: A Focus on UR-LA Cases" Cancers 17, no. 6: 1048.
https://doi.org/10.3390/cancers17061048
APA Style
Kishiwada, M., Mizuno, S., Hayasaki, A., Kaluba, B., Fujii, T., Noguchi, D., Ito, T., Iizawa, Y., Tanemura, A., Murata, Y., & Kuriyama, N.
(2025). Impact of Surgical Resection After Induction Gemcitabine Plus S-1-Based Chemoradiotherapy in Patients with Locally Advanced Pancreatic Ductal Adenocarcinoma: A Focus on UR-LA Cases. Cancers, 17(6), 1048.
https://doi.org/10.3390/cancers17061048